These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25514914)

  • 21. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.
    El-Kamary SS; Shardell MD; Abdel-Hamid M; Ismail S; El-Ateek M; Metwally M; Mikhail N; Hashem M; Mousa A; Aboul-Fotouh A; El-Kassas M; Esmat G; Strickland GT
    Phytomedicine; 2009 May; 16(5):391-400. PubMed ID: 19303273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats.
    Vessal G; Akmali M; Najafi P; Moein MR; Sagheb MM
    Ren Fail; 2010 Jul; 32(6):733-9. PubMed ID: 20540643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Milk thistle and the treatment of hepatitis.
    Giese LA
    Gastroenterol Nurs; 2001; 24(2):95-7. PubMed ID: 11847735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silymarin, a possible hepatoprotector in dairy cows: biochemical and histological observations.
    Tedesco D; Domeneghini C; Sciannimanico D; Tameni M; Steidler S; Galletti S
    J Vet Med A Physiol Pathol Clin Med; 2004 Mar; 51(2):85-9. PubMed ID: 15153078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases-A comprehensive narrative review.
    Jaffar HM; Al-Asmari F; Khan FA; Rahim MA; Zongo E
    Food Sci Nutr; 2024 May; 12(5):3097-3111. PubMed ID: 38726410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A silychristin isomer and variation of flavonolignan levels in milk thistle (Silybum marianum) fruits.
    Smith WA; Lauren DR; Burgess EJ; Perry NB; Martin RJ
    Planta Med; 2005 Sep; 71(9):877-80. PubMed ID: 16206045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
    Pradhan SC; Girish C
    Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the use of milk thistle (Silybum marianum).
    Post-White J; Ladas EJ; Kelly KM
    Integr Cancer Ther; 2007 Jun; 6(2):104-9. PubMed ID: 17548789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Milk thistle.
    Rainone F
    Am Fam Physician; 2005 Oct; 72(7):1285-8. PubMed ID: 16225032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease.
    Ball KR; Kowdley KV
    J Clin Gastroenterol; 2005 Jul; 39(6):520-8. PubMed ID: 15942440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of green tea in nonalcoholic fatty liver disease.
    Masterjohn C; Bruno RS
    Nutr Rev; 2012 Jan; 70(1):41-56. PubMed ID: 22221215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans.
    Chlopcíková S; Psotová J; Miketová P; Simánek V
    Phytother Res; 2004 Feb; 18(2):107-10. PubMed ID: 15022159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Effects of Milk Thistle (
    Doostkam A; Fathalipour M; Anbardar MH; Purkhosrow A; Mirkhani H
    Can J Gastroenterol Hepatol; 2022; 2022():2868904. PubMed ID: 35186807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
    Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
    Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
    Kidd P; Head K
    Altern Med Rev; 2005 Sep; 10(3):193-203. PubMed ID: 16164374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.
    Aghemo A; Alekseeva OP; Angelico F; Bakulin IG; Bakulina NV; Bordin D; Bueverov AO; Drapkina OM; Gillessen A; Kagarmanova EM; Korochanskaya NV; Kucheryavii UA; Lazebnik LB; Livzan MA; Maev IV; Martynov AI; Osipenko MF; Sas EI; Starodubova A; Uspensky YP; Vinnitskaya EV; Yakovenko EP; Yakovlev AA
    Ann Med; 2022 Dec; 54(1):1548-1560. PubMed ID: 35635048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatoprotective mechanism of
    Jiang G; Sun C; Wang X; Mei J; Li C; Zhan H; Liao Y; Zhu Y; Mao J
    Bioengineered; 2022 Mar; 13(3):5216-5235. PubMed ID: 35170400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts.
    Kidd PM
    Altern Med Rev; 2009 Sep; 14(3):226-46. PubMed ID: 19803548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Milk Thistle (Silybum Marianum) as a Supportive Phytotherapeutic Agent in Oncology].
    Frassová Z; Rudá-Kučerová J
    Klin Onkol; 2017; 30(6):426-432. PubMed ID: 29271213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin.
    Polyak SJ; Morishima C; Shuhart MC; Wang CC; Liu Y; Lee DY
    Gastroenterology; 2007 May; 132(5):1925-36. PubMed ID: 17484885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.